Published in BJU Int on November 02, 2010
Dose-dependent ATP depletion and cancer cell death following calcium electroporation, relative effect of calcium concentration and electric field strength. PLoS One (2015) 1.46
Electrochemotherapy: from the drawing board into medical practice. Biomed Eng Online (2014) 1.25
Irreversible electroporation: treatment effect is susceptible to local environment and tissue properties. Radiology (2013) 1.11
Irreversible electroporation: state of the art. Onco Targets Ther (2016) 0.90
Ablative therapies for small renal tumours. Nat Rev Urol (2013) 0.85
The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol. BMC Cancer (2015) 0.84
Electric Ablation with Irreversible Electroporation (IRE) in Vital Hepatic Structures and Follow-up Investigation. Sci Rep (2015) 0.83
Electrochemotherapy of colorectal liver metastases--an observational study of its effects on the electrocardiogram. Biomed Eng Online (2015) 0.80
Irreversible electroporation of human primary uveal melanoma in enucleated eyes. PLoS One (2013) 0.78
Renal preservation therapy for renal cell carcinoma. Int J Surg Oncol (2012) 0.78
Renal ablation update. Semin Intervent Radiol (2014) 0.77
Irreversible electroporation of small renal masses: suboptimal oncologic efficacy in an early series. World J Urol (2017) 0.76
Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b). JMIR Res Protoc (2017) 0.75
Successful ablation of lymph nodes using irreversible electroporation (IRE) in a porcine survival model. Langenbecks Arch Surg (2017) 0.75
BAP1 loss defines a new class of renal cell carcinoma. Nat Genet (2012) 4.97
Single-incision, umbilical laparoscopic versus conventional laparoscopic nephrectomy: a comparison of perioperative outcomes and short-term measures of convalescence. Eur Urol (2008) 4.09
Ten-Year Outcomes of Renal Tumor Radio Frequency Ablation. J Urol (2019) 3.20
Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer. Eur Urol (2009) 2.76
Laparoendoscopic single-site surgery in urology: worldwide multi-institutional analysis of 1076 cases. Eur Urol (2011) 2.46
Patient-reported body image and cosmesis outcomes following kidney surgery: comparison of laparoendoscopic single-site, laparoscopic, and open surgery. Eur Urol (2011) 2.34
Laparoendoscopic single-site and natural orifice transluminal endoscopic surgery in urology: a critical analysis of the literature. Eur Urol (2010) 2.28
Laboratory and clinical development of single keyhole umbilical nephrectomy. Urology (2007) 2.28
The value of your time: evaluation of effects of changes in medicare reimbursement rates on the practice of urology. J Urol (2004) 2.23
Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer. Urology (2009) 2.17
Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. Proc Natl Acad Sci U S A (2010) 2.16
Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol (2007) 2.07
Phase one pilot study using magnetic resonance spectroscopy to predict the histology of radiofrequency-ablated renal tissue. Eur Urol (2008) 2.03
The new economics of radical prostatectomy: cost comparison of open, laparoscopic and robot assisted techniques. J Urol (2004) 1.97
Perioperative outcomes in patients undergoing conventional laparoscopic versus laparoendoscopic single-site pyeloplasty. Urology (2009) 1.96
A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma. Sci Transl Med (2012) 1.84
Cost comparison of robotic, laparoscopic, and open partial nephrectomy. J Endourol (2011) 1.83
Cost-effectiveness of medical management strategies for nephrolithiasis. J Urol (2004) 1.81
Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol (2012) 1.78
Current status and future directions of robotic single-site surgery: a systematic review. Eur Urol (2012) 1.63
Single-incision laparoscopic surgery: initial urological experience and comparison with natural-orifice transluminal endoscopic surgery. BJU Int (2008) 1.62
Laparoendoscopic single-site surgery in urology: where have we been and where are we heading? Nat Clin Pract Urol (2008) 1.62
Completely transvaginal NOTES cholecystectomy using magnetically anchored instruments. Surg Endosc (2007) 1.61
Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery. BJU Int (2008) 1.60
Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer (2010) 1.58
Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours. BJU Int (2013) 1.58
Management of ureteral calculi: a cost comparison and decision making analysis. J Urol (2002) 1.57
Trocar-less instrumentation for laparoscopy: magnetic positioning of intra-abdominal camera and retractor. Ann Surg (2007) 1.57
Minimally invasive nephrectomy: the influence of laparoendoscopic single-site surgery on patient selection, outcomes, and morbidity. Urology (2010) 1.54
Implications of the prostate cancer prevention trial: a decision analysis model of survival outcomes. J Clin Oncol (2005) 1.54
Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol (2009) 1.52
Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration. BJU Int (2011) 1.50
Urological laparoendoscopic single site surgery: multi-institutional analysis of risk factors for conversion and postoperative complications. J Urol (2012) 1.50
Prognostic value of syndecan-1 expression in patients treated with radical prostatectomy. BJU Int (2007) 1.50
Consensus statement on natural orifice transluminal endoscopic surgery and single-incision laparoscopic surgery: heralding a new era in urology? Eur Urol (2008) 1.48
Training on a virtual reality laparoscopic simulator improves performance of an unfamiliar live laparoscopic procedure. J Urol (2008) 1.48
Sirolimus in metatastic renal cell carcinoma. J Clin Oncol (2008) 1.47
Laparoscopic radical nephrectomy: oncologic efficacy. Urol Clin North Am (2003) 1.47
Laparoscopic partial nephrectomy using holmium laser in a porcine model. JSLS (2004) 1.46
Multi-institutional survey of laparoscopic ureterolysis for retroperitoneal fibrosis. Urology (2007) 1.46
Robot-assisted laparoendoscopic single-site pyeloplasty: technique using the da Vinci Si robotic platform. J Endourol (2012) 1.45
Laparoendoscopic single-site nephrectomy compared with conventional laparoscopic nephrectomy: a 5-year, single-surgeon experience. Eur Urol (2013) 1.44
Importance of cosmesis to patients undergoing renal surgery: a comparison of laparoendoscopic single-site (LESS), laparoscopic and open surgery. BJU Int (2011) 1.43
Selective prostate cancer thermal ablation with laser activated gold nanoshells. J Urol (2007) 1.42
Radiofrequency ablation of incidental benign small renal mass: outcomes and follow-up protocol. Urology (2012) 1.40
Transvaginal laparoscopic nephrectomy: development and feasibility in the porcine model. Urology (2002) 1.40
Rendering stone fragments paramagnetic with iron-oxide microparticles improves the efficiency and effectiveness of endoscopic stone fragment retrieval. Urology (2010) 1.39
Surgical simulation: a urological perspective. J Urol (2008) 1.34
Interplay between pVHL and mTORC1 pathways in clear-cell renal cell carcinoma. Mol Cancer Res (2011) 1.33
Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. J Urol (2004) 1.31
Treatment of localised renal cell carcinoma. Eur Urol (2011) 1.29
Laparoscopic partial nephrectomy with a diode laser: porcine results. J Endourol (2002) 1.29
Natural history of residual fragments following percutaneous nephrostolithotomy. J Urol (2009) 1.24
Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol (2006) 1.23
Efficacy and safety of fast-track recovery strategy for patients undergoing laparoscopic nephrectomy. J Endourol (2005) 1.22
Histopathology of surgically managed renal tumors: analysis of a contemporary series. Urology (2003) 1.22
Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol (2009) 1.21
Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter: size matters. J Urol (2012) 1.21
Prostate cancer radiosensitization through poly(ADP-Ribose) polymerase-1 hyperactivation. Cancer Res (2010) 1.20
Contemporary management of small renal masses. Eur Urol (2011) 1.19
Single trocar laparoscopic nephrectomy using magnetic anchoring and guidance system in the porcine model. J Urol (2007) 1.18
Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int (2007) 1.17
Role of magnetic anchors during laparoendoscopic single site surgery and NOTES. J Endourol (2009) 1.15
Radiofrequency ablation of renal tumors: intermediate-term results. J Endourol (2006) 1.12
Where do we really stand with LESS and NOTES? Eur Urol (2010) 1.11
The effect of the approach to radical prostatectomy on the profitability of hospitals and surgeons. BJU Int (2009) 1.10
Sirolimus and temsirolimus for epithelioid angiomyolipoma. J Clin Oncol (2010) 1.10
Re: A multinational, multi-institutional study comparing positive surgical margin rates among 22393 open, laparoscopic, and robot-assisted radical prostatectomy patients. J Urol (2015) 1.06
International comparison of cost effectiveness of medical management strategies for nephrolithiasis. Urol Res (2005) 1.06
Resorbable clip migration in the collecting system after laparoscopic partial nephrectomy. Urology (2006) 1.04
Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy. Clin Cancer Res (2009) 1.04
Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int (2008) 1.03
Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model. Eur Urol (2006) 1.03
Robotic percutaneous access to the kidney: comparison with standard manual access. J Endourol (2002) 1.01
Cytokine response to surgical stress: comparison of pure laparoscopic, hand-assisted laparoscopic, and open nephrectomy. J Endourol (2005) 1.01
Virtual ureteroscopy predicts ureteroscopic proficiency of medical students on a cadaver. J Urol (2004) 1.00
Prediction of perioperative outcomes following minimally invasive partial nephrectomy: role of the R.E.N.A.L nephrometry score. World J Urol (2012) 0.99
Active DLP hyperspectral illumination: a noninvasive, in vivo, system characterization visualizing tissue oxygenation at near video rates. Anal Chem (2011) 0.99
Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors. Urology (2005) 0.99
Clinical use of the holmium: YAG laser in laparoscopic partial nephrectomy. J Endourol (2002) 0.99
Nicotinamide adenine dinucleotide staining immediately following radio frequency ablation of renal tumors-is a positive stain synonymous with ablative failure? J Urol (2006) 0.98
Efficacy of laser-activated gold nanoshells in ablating prostate cancer cells in vitro. J Endourol (2007) 0.98
Perioperative comparison of robotic assisted laparoendoscopic single-site (LESS) pyeloplasty versus conventional LESS pyeloplasty. Eur Urol (2011) 0.97
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. J Urol (2012) 0.96
Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions. Surgery (2010) 0.95
Cell-type-dependent regulation of mTORC1 by REDD1 and the tumor suppressors TSC1/TSC2 and LKB1 in response to hypoxia. Mol Cell Biol (2011) 0.95
Characterization of renal ischemia using DLP hyperspectral imaging: a pilot study comparing artery-only occlusion versus artery and vein occlusion. J Endourol (2010) 0.95
Complications and conversions of upper tract urological laparoendoscopic single-site surgery (LESS): multicentre experience: results from the NOTES Working Group. BJU Int (2010) 0.94
Pseudosarcomatous fibromyxoid tumor of the bladder. Urol Oncol (2007) 0.94
Irreversible electroporation: evaluation of nonthermal and thermal ablative capabilities in the porcine kidney. Urology (2013) 0.93
Assessment of basic human performance resources predicts operative performance of laparoscopic surgery. J Am Coll Surg (2003) 0.93
A novel magnetic anchoring and guidance system to facilitate single trocar laparoscopic nephrectomy. Curr Urol Rep (2008) 0.93
Functional assessment of crossing vessels as etiology of ureteropelvic junction obstruction. Urology (2007) 0.93
Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques. BJU Int (2009) 0.92
Complications during the initial experience with laparoendoscopic single-site pyeloplasty. BJU Int (2011) 0.92